BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong Meeks, Pascal Guénel, Joe Dennis et al.|JNCI Journal of the National Cancer Institute|2015Cited by 92
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Alan Donaldson, Claire Bardel et al.|Breast Cancer Research|2015Cited by 35